0
0
1/30/23 at 1:51pm
Organization
News-Medical.Net
46 words
0
Comments
Researchers evaluated the safety profiles of booster doses of the monovalent and bivalent mRNA COVID-19 vaccine BNT162b2 in adults above the age of 60.
You are the first to view
https://www.news-medical.net/news/20230130/The-safety-profile-of-the-first-and-second-monovalent-and-bivalent-BNT162b2-mRNA-booster-vaccines-in-older-adults.aspx
Create an account
or login to join the discussion